Sumi Shrishrimal Sells 1,131 Shares of iRhythm Technologies, Inc. (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc. (NASDAQ:IRTCGet Free Report) EVP Sumi Shrishrimal sold 1,131 shares of the company’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $88.91, for a total value of $100,557.21. Following the sale, the executive vice president now owns 23,298 shares of the company’s stock, valued at approximately $2,071,425.18. The transaction was disclosed in a filing with the SEC, which is accessible through this link.

iRhythm Technologies Stock Performance

Shares of NASDAQ:IRTC opened at $97.85 on Friday. The business has a 50 day moving average price of $103.13 and a 200 day moving average price of $105.50. iRhythm Technologies, Inc. has a twelve month low of $70.24 and a twelve month high of $124.11. The company has a debt-to-equity ratio of 7.13, a quick ratio of 6.95 and a current ratio of 7.10.

iRhythm Technologies (NASDAQ:IRTCGet Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported ($1.47) EPS for the quarter, missing analysts’ consensus estimates of ($0.99) by ($0.48). iRhythm Technologies had a negative return on equity of 69.87% and a negative net margin of 25.33%. The firm had revenue of $131.93 million during the quarter, compared to the consensus estimate of $128.87 million. As a group, equities analysts predict that iRhythm Technologies, Inc. will post -3.22 EPS for the current fiscal year.

Institutional Trading of iRhythm Technologies

Hedge funds have recently modified their holdings of the company. Artisan Partners Limited Partnership lifted its position in shares of iRhythm Technologies by 5.5% in the 4th quarter. Artisan Partners Limited Partnership now owns 2,071,500 shares of the company’s stock worth $221,733,000 after acquiring an additional 108,875 shares during the period. Norges Bank bought a new stake in shares of iRhythm Technologies in the 4th quarter worth approximately $26,522,000. Stephens Investment Management Group LLC lifted its position in shares of iRhythm Technologies by 17.4% in the 4th quarter. Stephens Investment Management Group LLC now owns 359,225 shares of the company’s stock worth $38,451,000 after acquiring an additional 53,219 shares during the period. Canada Pension Plan Investment Board acquired a new position in shares of iRhythm Technologies in the 3rd quarter worth approximately $1,046,000. Finally, Braidwell LP raised its holdings in shares of iRhythm Technologies by 18.7% in the 3rd quarter. Braidwell LP now owns 568,157 shares of the company’s stock worth $53,554,000 after buying an additional 89,600 shares in the last quarter.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on IRTC shares. Canaccord Genuity Group decreased their price target on iRhythm Technologies from $133.00 to $122.00 and set a “buy” rating for the company in a research note on Friday, May 3rd. JPMorgan Chase & Co. decreased their price target on iRhythm Technologies from $142.00 to $133.00 and set an “overweight” rating for the company in a research note on Friday, February 23rd. Finally, Needham & Company LLC increased their target price on iRhythm Technologies from $137.00 to $138.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. One equities research analyst has rated the stock with a sell rating and seven have issued a buy rating to the company’s stock. Based on data from MarketBeat, iRhythm Technologies presently has an average rating of “Moderate Buy” and an average price target of $134.00.

Read Our Latest Stock Analysis on iRhythm Technologies

iRhythm Technologies Company Profile

(Get Free Report)

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.

Featured Stories

Receive News & Ratings for iRhythm Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRhythm Technologies and related companies with MarketBeat.com's FREE daily email newsletter.